These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16837793)

  • 1. Response to long-term growth hormone therapy in short children with reduced GH bioactivity.
    Travaglino P; Buzi F; Meazza C; Pagani S; Tinelli C; Iughetti L; De Sanctis V; Aimaretti G; Poddighe D; Barberi S; Bozzola M
    Horm Res; 2006; 66(4):189-94. PubMed ID: 16837793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand.
    Wacharasindhu S; Supornsilchai V; Aroonparkmongkol S; Srivuthana S
    J Med Assoc Thai; 2007 Oct; 90(10):2047-52. PubMed ID: 18041422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in serum GH cut-off values for pharmacological tests of GH secretion depend on the serum GH method. Clinical validation from the growth velocity score during the first year of treatment.
    Chaler EA; Rivarola MA; Guerci B; Ciaccio M; Costanzo M; Travaglino P; Maceiras M; Pagani S; Meazza C; Bozzola E; Barberi S; Bozzola M; Belgorosky A
    Horm Res; 2006; 66(5):231-5. PubMed ID: 16912509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
    Arends NJ; Boonstra VH; Mulder PG; Odink RJ; Stokvis-Brantsma WH; Rongen-Westerlaken C; Mulder JC; Delemarre-Van de Waal H; Reeser HM; Jansen M; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):779-87. PubMed ID: 14974922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of growth hormone deficiency and recombinant hGH (rhGH) replacement on the hypothalamic-pituitary-adrenal axis in children with idiopathic isolated GH deficiency.
    Giavoli C; Bergamaschi S; Ferrante E; Ronchi CL; Lania AG; Rusconi R; Spada A; Beck-Peccoz P
    Clin Endocrinol (Oxf); 2008 Feb; 68(2):247-51. PubMed ID: 17868384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant hGH replacement therapy and the hypothalamus-pituitary-thyroid axis in children with GH deficiency: when should we be concerned about the occurrence of central hypothyroidism?
    Giavoli C; Porretti S; Ferrante E; Cappiello V; Ronchi CL; Travaglini P; Epaminonda P; Arosio M; Beck-Peccoz P
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):806-10. PubMed ID: 14974926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final height in children with idiopathic growth hormone deficiency treated with a fixed dose of recombinant growth hormone.
    Rachmiel M; Rota V; Atenafu E; Daneman D; Hamilton J
    Horm Res; 2007; 68(5):236-43. PubMed ID: 17396034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acromegalic features in growth hormone (GH)-deficient patients after long-term GH therapy.
    Carvalho LR; de Faria ME; Osorio MG; Estefan V; Jorge AA; Arnhold IJ; Mendonca BB
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):788-92. PubMed ID: 14974923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement.
    Esposito V; Di Biase S; Lettiero T; Labella D; Simeone R; Salerno M
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):607-11. PubMed ID: 15521964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.
    Grumbach MM; Bin-Abbas BS; Kaplan SL
    Horm Res; 1998; 49 Suppl 2():41-57. PubMed ID: 9730672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF-alpha levels in children with growth hormone deficiency and the effect of long-term growth hormone replacement therapy.
    Andiran N; Yordam N
    Growth Horm IGF Res; 2007 Apr; 17(2):149-53. PubMed ID: 17314057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of long-term growth hormone therapy on bone age and pubertal maturation in boys with and without classic growth hormone deficiency.
    Zadik Z; Chalew S; Zung A; Landau H; Leiberman E; Koren R; Voet H; Hochberg Z; Kowarski AA
    J Pediatr; 1994 Aug; 125(2):189-95. PubMed ID: 8040760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic outcome of GH treatment in prepubertal short children with and without classical GH deficiency.
    Decker R; Albertsson-Wikland K; Kriström B; Nierop AF; Gustafsson J; Bosaeus I; Fors H; Hochberg Z; Dahlgren J
    Clin Endocrinol (Oxf); 2010 Sep; 73(3):346-54. PubMed ID: 20455890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone (GH) secretion and pituitary size in children with short stature. Efficacy of GH therapy in GH-deficient children, depending on the pituitary size.
    Hilczer M; Szalecki M; Smyczynska J; Stawerska R; Kaniewska D; Lewinski A
    Neuro Endocrinol Lett; 2005 Oct; 26(5):447-52. PubMed ID: 16264418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
    Darendeliler F; Ranke MB; Bakker B; Lindberg A; Cowell CT; Albertsson-Wikland K; Reiter EO; Price DA
    Horm Res; 2005; 63(1):40-7. PubMed ID: 15627781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
    Zenaty D; Garel C; Limoni C; Czernichow P; Léger J
    Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced insulin sensitivity during growth hormone therapy for short children born small for gestational age.
    Cutfield WS; Jackson WE; Jefferies C; Robinson EM; Breier BH; Richards GE; Hofman PL
    J Pediatr; 2003 Feb; 142(2):113-6. PubMed ID: 12584529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth and growth hormone therapy in children with achondroplasia: a two-year experience.
    Stamoyannou L; Karachaliou F; Neou P; Papataxiarchou K; Pistevos G; Bartsocas CS
    Am J Med Genet; 1997 Oct; 72(1):71-6. PubMed ID: 9295079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.